Drug Facts
Active ingredient
Octinoxate 7.50%
Titanium Dioxide 5.19%
Octisalate 3.00%
The following Structured Product Label (SPL) was submitted to the FDA by Cellinbio Co Ltd for the product Rendrevie Sun Screen Spf35 Pa (NDC 76173-1001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, purpose, keep out of reach of children, indication & usage, warnings, dosage & administration, inactive ingredient, rendrevie sun screen spf35 pa++, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredient
Octinoxate 7.50%
Titanium Dioxide 5.19%
Octisalate 3.00%
Sunscreen
Keep out of reach of children
If swallowed, get medical help or contact a Posion Control Center right away.
Warnings
Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging
For extenal use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.
Helps prevent sunburn
Water, Cyclopentasiloxane, Glycerin, Dipropylene Glycol, Peg-10 Dimethicone, Hexyl Laurate, Talc, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Disteardimonium Hectorite, Magnesium Sulfate, Aluminum Hydroxide, Aluminum Stearate, Fragrance, Imidazolidinyl Urea, Methylparaben, Propylparaben, Aloe Barbadensis Leaf Juice, Chamomilla Recutita(Matricaria) Flower Extract, Lavandula Angustifolia(Lavender) Extract, Panax Ginseng Root Extract, Squalane, Iron Oxides(CI 77492, CI 77491, CI 77499), Butylparaben, Methicone
* Please review the disclaimer below.